A non-ablative erbium glass fractional laser, followed by the application of 0.05% topical finasteride and growth factors (including bFGF, IGF, VEGF, and 1% copper peptide), was applied to treat four AGA patients, resulting in improved hair regrowth and density
We considered that a consensus was reached when the lower bound of the 95% confidence interval was 50% or higher
For most protocols, this variance is within acceptable margins, but dose-response studies requiring sub-milligram precision should use third-party CoA documentation to confirm exact peptide content
Gastrointestinal Support: BPC-157 shows gastroprotective and ulcer-healing effects in preclinical studies [2]
Semaglutide and Tirzepatide are GLP-1 weight-loss medication options, not vitamin injections
Interested in the science behind evidence-based metabolic support